본문으로 건너뛰기
← 뒤로

Differentiation of focal liver lesions in contrast-enhanced ultrasound using a heuristic-guided hybrid machine-learning framework.

1/5 보강
Journal of medical ultrasonics (2001) 2026
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
232 patients with 232 focal liver lesions (benign: 61, hepatocellular carcinoma [HCC]: 104, non-HCC malignancies [ML]: 67) were analyzed.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
For discrimination between benign and malignant, the mean AUC for the three observers was significantly improved with AI output, where the difference in AUC (95% confidence interval) was 0.095 (0.0197, 0.1703) (P = 0.013). [CONCLUSIONS] The proposed AI-based framework enables accurate liver lesion classification using early phase CEUS, eliminating the need for Kupffer-phase imaging in many cases.

Nakajima K, Kamiyama N, Sugimoto K, Hashimoto H, Itoi T

📝 환자 설명용 한 줄

[PURPOSE] Sonazoid contrast-enhanced ultrasound (CEUS) offers valuable diagnostic information on hepatic lesions, but it is time-consuming.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P = 0.013
  • Sensitivity 94.8%
  • Specificity 94.8%

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Nakajima K, Kamiyama N, et al. (2026). Differentiation of focal liver lesions in contrast-enhanced ultrasound using a heuristic-guided hybrid machine-learning framework.. Journal of medical ultrasonics (2001). https://doi.org/10.1007/s10396-025-01598-1
MLA Nakajima K, et al.. "Differentiation of focal liver lesions in contrast-enhanced ultrasound using a heuristic-guided hybrid machine-learning framework.." Journal of medical ultrasonics (2001), 2026.
PMID 41610000

Abstract

[PURPOSE] Sonazoid contrast-enhanced ultrasound (CEUS) offers valuable diagnostic information on hepatic lesions, but it is time-consuming. In this study, we investigated a novel composite machine-learning framework that integrates heuristic knowledge and model-specific classification to differentiate liver lesions using only the first 2 min of CEUS imaging.

[METHODS] CEUS images from 232 patients with 232 focal liver lesions (benign: 61, hepatocellular carcinoma [HCC]: 104, non-HCC malignancies [ML]: 67) were analyzed. For each case, six frames from injection to peak enhancement and static images at 1 and 2 min post-injection were used. Two deep learning models were developed: Model 1 classified heterogeneous enhancement patterns into "benign," "HCC," "ML," or "Uniform" (homogeneous). Model 2 further classified "Uniform" cases into three diagnostic categories. Lesion brightness values were incorporated as input features. The artificial intelligence (AI) mode was also evaluated by observer study of three hepatologists using the area under the receiver operating characteristic curve (AUC).

[RESULTS] The composite model was evaluated on 58 independent test cases, achieving classification accuracy of 81.8% for benign, 93.5% for HCC, and 68.8% for ML, with an overall accuracy of 84.5%. Binary classification (benign vs. malignant) yielded 97.9% sensitivity, 94.8% specificity, and 94.8% overall accuracy. For discrimination between benign and malignant, the mean AUC for the three observers was significantly improved with AI output, where the difference in AUC (95% confidence interval) was 0.095 (0.0197, 0.1703) (P = 0.013).

[CONCLUSIONS] The proposed AI-based framework enables accurate liver lesion classification using early phase CEUS, eliminating the need for Kupffer-phase imaging in many cases.

같은 제1저자의 인용 많은 논문 (4)